Made by Ziska Pharmaceuticals Ltd., Bilargo is a dispersible tablet whose active ingredient is Bilastine. The medicine helps relieve symptoms linked to these allergic reactions.
There are 82 brands of Bilastine listed in Bangladesh. By unit price, Bilargo is among the cheapest of them. The lowest listed price is Blastine 20 mg Tablet at ৳ 10 per unit.
What is Bilargo 10 mg Dispersible Tablet?
The dispersible tablet Bilargo contains Bilastine and is made by Ziska Pharmaceuticals Ltd. It is used for the symptomatic treatment of allergic rhino-conjunctivitis, both seasonal and perennial, and urticaria. It is classified as a non-sedating antihistamine, meaning it is less likely to cause drowsiness than older antihistamines. The doctor decides the dose and course for each child.
Uses of Bilargo
The medicine helps relieve symptoms linked to these allergic reactions. This medicine helps relieve these symptoms but does not treat the underlying allergy itself. Allergic rhino-conjunctivitis involves allergic symptoms affecting the nose and eyes, while urticaria refers to a type of allergic skin reaction. Your doctor will confirm whether this medicine is appropriate for your symptoms and what else may be needed.
How to use Bilargo
If you are unsure how to take it or what to do about a missed dose, ask your doctor or pharmacist for advice. Swallow the dispersible tablet with water. Bilargo is taken by mouth. Complete the course exactly as prescribed. Do not change the dose or stop the course without asking the doctor.
Side effects of Bilargo
Contact the doctor if a side effect is troublesome, does not go away, or if your child seems unwell. Do not start or stop any medicine without their guidance. Not every child will have side effects. Tell your doctor if you notice any of these or any other unusual effect. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
There are no or limited data on its use in pregnant women, and as a precaution it is preferable to avoid during pregnancy. Co-administration with P-glycoprotein inhibitors such as ketoconazole, erythromycin, cyclosporine, ritonavir or diltiazem should be avoided in patients with moderate or severe renal impairment. Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Bilargo treat?
The medicine helps relieve symptoms linked to these allergic reactions. This medicine helps relieve these symptoms but does not treat the underlying allergy itself.
How do I use Bilargo correctly?
If you are unsure how to take it or what to do about a missed dose, ask your doctor or pharmacist for advice. Swallow the dispersible tablet with water.
What should I watch for while using Bilargo?
Contact the doctor if a side effect is troublesome, does not go away, or if your child seems unwell. Do not start or stop any medicine without their guidance.
Bilastine is indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
Pharmacology
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H 1 receptor antagonist affinity and no affinity for muscarinic receptors. Bilastine inhibits histamine-induced wheal and flare skin reactions for 24 hours following single doses.
Dosage & Administration
Adults & adolescents (12 years of age and over): 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.
Children between 6 to 11 years: 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.
Children between 2 to 11 years: 4 ml once daily.
Interaction
Concomitant intake of Bilastine and Ketoconazole or Erythromycin or Diltiazem increased C max of Bilastine. The psychomotor performance after concomitant intake of alcohol and Bilastine was similar to that observed after intake of alcohol and placebo. Concomitant intake of Bilastine and Lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of Lorazepam.
Contraindications
Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.
Side Effects
The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.
Pregnancy & Lactation
There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.
Precautions & Warnings
Co-administration of Bilastine and P-glycoprotein inhibitors (e.g. Ketoconazole, Erythromycin, Cyclosporine, Ritonavir or Diltiazem) should be avoided in patients with moderate or severe renal impairment.
Overdose Effects
In clinical trials, after administration of Bilastine at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.
Storage Conditions
Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.
Alternative brands of Bilastine
Other brands with the same generic name, cheapest first.